Position in SRPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$28,578,248
-$10,285,568 QoQ
Shares Held
1,590,331
-11.0% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#16
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. SRPT ranks #28 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,578,248 | 1,590,331 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $38,863,816 | 1,786,021 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $28,262,495 | 1,313,313 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $25,218,475 | 1,308,691 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $22,370,202 | 1,308,199 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $18,643,736 | 292,130 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $46,255,023 | 380,418 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $63,548,527 | 508,836 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $80,315,982 | 508,329 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $78,998,562 | 610,216 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $68,310,047 | 708,390 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $116,740,799 | 963,049 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $110,505,730 | 964,947 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $112,596,358 | 816,922 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $101,000,223 | 779,443 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $85,654,571 | 774,874 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,779,336 | 704,100 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $54,963,903 | 703,583 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $61,141,608 | 678,974 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $30,420,462 | 328,941 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,575,692 | 226,083 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $20,982,803 | 281,535 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $48,406,543 | 283,926 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $43,363,800 | 308,793 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $35,882,487 | 223,790 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $19,437,224 | 198,704 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||